Skip to content

Comparison of ringer with ringer lactate as a prime solution in coronary artery bypass graft

Comparison of ringer with ringer lactate as a prime solution in coronary artery bypass graft

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141009019470N94
Enrollment
54
Registered
2020-01-10
Start date
2020-02-04
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Graft Surgery. Atherosclerotic heart disease of native coronary artery

Interventions

Intervention 1: Intervention group1: Oxygenator content contains 1600 cc of prime solution including heparin, hydroxyethyl starch and ringer. Intervention 2: Intervention group2: Oxygenator content co

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients Candidate for Coronary Artery Bypass Graft Surgery Age 20 to 75 years Weight less than 50 kg and over 100 kg

Exclusion criteria

Exclusion criteria: Cardiopulmonary pump duration over 3 hours Emergency surgery Chronic renal failure Anemia (Hb <10 g / dl) Coagulopathy Pulmonary Failure Diabetes mellitus Liver problem Acid-disorder disturbance

Design outcomes

Primary

MeasureTime frame
Blood PH. Timepoint: 15 minutes after the start of cardiopulmonary bypass, in the warm-up phase at 34 ° C. Method of measurement: Arterial blood sample.;Serum bicarbonate level. Timepoint: 15 minutes after the start of cardiopulmonary bypass, in the warm-up phase at 34 ° C. Method of measurement: Arterial blood sample.

Secondary

MeasureTime frame
Base excess. Timepoint: 15 minutes after the start of cardiopulmonary bypass, in the warm-up phase at 34 ° C. Method of measurement: Arterial blood sample.;PaCO2. Timepoint: 15 minutes after the start of cardiopulmonary bypass, in the warm-up phase at 34 ° C. Method of measurement: Arterial blood sample.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGhasem Ghasempour

Shiraz University of Medical Sciences

ghasemghasempoor@gmail.com+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026